AHH will make an investment of Rs. 600 crore in the company through a mix of primary and secondary infusion
The campaign for the digital film is being amplified across various digital media platforms such as YouTube, Facebook, Instagram, Twitter, and LinkedIn
InvaGen has received 5 inspectional observations in Form 483
The market capitalization of the company stood at Rs. 7,000 crore +
The partnership is part of BioNTech’s strategy to develop novel prophylactic vaccines for the prevention of high-medical-need infectious diseases
Luran S MED 797S SPF30 is one of the first ASA materials in the market specifically for medical device housings
The complexity of operating on a one-year-old are many with the organs being tiny, fragile
Bains has stepped down from his role on the Biocon Board as an Independent Director with immediate effect
CureVac is among many pharmaceutical companies looking to produce a novel seasonal influenza vaccine via mRNA technology
The Government of India continues to prioritise initiatives aimed at enhancing the accessibility and equity of health services
Subscribe To Our Newsletter & Stay Updated
